How about one of the most renowned cancer centers that KNOW Kevetrin intimately had this to say - 'Elsewhere, when we mentioned the bioavailability achieved in oral Kevetrin to scientists at our previous Phase 1 clinical site, they commented that it could represent a significant improvement to lengthy or frequent intravenous infusions and urged us to select them as a site for future Kevetrin trials.'

Sounds excellent!